![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Genome-wide Association Analysis to Evaluate Genetic Variations Associated with Rash Development in Telaprevir Phase 2 and 3 Studies
|
|
|
Reported by Jules Levin
AASLD 2013 Nov 1-5 Wash DC
Jim C. Sullivan1, Darin Takemoto1, Jeroen Aerssens2, Kevin Kelliher1, Brian Hare1, Leif Bengtsson1, Raymond Rubin1, David Goldstein3, Martyn Botfield1
1Vertex Pharmaceuticals Incorporated, Cambridge, MA, USA; 2. Janssen Infectious Diseases BVBA, Beerse, Belgium; 3. Human Genome Research Institute, Duke University School of Medicine, Durham, NC, USA
![AASLD1.gif](../images/120113/120113-4/AASLD1.gif)
![AASLD2.gif](../images/120113/120113-4/AASLD2.gif)
![AASLD3.gif](../images/120113/120113-4/AASLD3.gif)
![AASLD4.gif](../images/120113/120113-4/AASLD4.gif)
![AASLD5.gif](../images/120113/120113-4/AASLD5.gif)
![AASLD6.gif](../images/120113/120113-4/AASLD6.gif)
![AASLD7.gif](../images/120113/120113-4/AASLD7.gif)
![AASLD8.gif](../images/120113/120113-4/AASLD8.gif)
![AASLD9.gif](../images/120113/120113-4/AASLD9.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|